Literature DB >> 8628250

Stable transformation and regulated expression of an inducible reporter construct in Candida albicans using restriction enzyme-mediated integration.

D H Brown1, I V Slobodkin, C A Kumamoto.   

Abstract

To allow the regulated expression of cloned genes in Candida albicans, a plasmid was constructed using the inducible promoter of the C. Albicans MAL2 gene. To demonstrate that the MAL2 promoter could regulate cloned genes placed under its control, a fusion construct was made with the coding sequence of the C. albicans URA3 gene. This plasmid was introduced into a Ura- strain of C. albicans using the process of restriction enzyme-mediated integration (REMI). This procedure involves the transformation of the BamHI-linearized plasmid in the presence of BamHI enzyme. The majority of transformants generated contained insertions of the plasmid at chromosomal BamHI sites. All transformants examined were inducible for URA3 expression, which was determined by growth analysis and by measuring the level of URA3 gene product activity. The URA+ phenotype of the transformants was stable during growth under nonselective conditions. This system offers the advantages of stable transformation, easy recovery of integrated DNA, and inducible expression of genes in C. albicans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628250     DOI: 10.1007/bf02174347

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  24 in total

1.  Directed mutagenesis in Candida albicans: one-step gene disruption to isolate ura3 mutants.

Authors:  R Kelly; S M Miller; M B Kurtz; D R Kirsch
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  Purification and properties of orotidine-5'-phosphate pyrophosphorylase and orotidine-5'-phosphate decarboxylase from baker's yeast.

Authors:  K Umezu; T Amaya; A Yoshimoto; K Tomita
Journal:  J Biochem       Date:  1971-08       Impact factor: 3.387

Review 3.  The emergence of fungi as major hospital pathogens.

Authors:  G P Bodey
Journal:  J Hosp Infect       Date:  1988-02       Impact factor: 3.926

4.  Use of URA3 as a reporter of gene expression in C. albicans.

Authors:  K K Myers; P S Sypherd; W A Fonzi
Journal:  Curr Genet       Date:  1995-02       Impact factor: 3.886

5.  The in situ assay of Candida albicans enzymes during yeast growth and germ-tube formation.

Authors:  S P Ram; P A Sullivan; M G Shepherd
Journal:  J Gen Microbiol       Date:  1983-08

6.  Construction of glucose-repressible yeast expression vectors.

Authors:  B Yao; J Marmur; P Sollitti
Journal:  Gene       Date:  1993-12-31       Impact factor: 3.688

7.  Cloning and characterization of a Candida albicans maltase gene involved in sucrose utilization.

Authors:  A Geber; P R Williamson; J H Rex; E C Sweeney; J E Bennett
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

8.  Upstream regulatory regions controlling the expression of the yeast maltase gene.

Authors:  S H Hong; J Marmur
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

9.  A reorganized Candida albicans DNA sequence promoting homologous non-integrative genetic transformation.

Authors:  E Herreros; M I García-Sáez; C Nombela; M Sánchez
Journal:  Mol Microbiol       Date:  1992-12       Impact factor: 3.501

10.  Morphogenesis-independent regulation of actin transcript levels in the pathogenic yeast Candida albicans.

Authors:  S Delbrück; J F Ernst
Journal:  Mol Microbiol       Date:  1993-11       Impact factor: 3.501

View more
  16 in total

Review 1.  Molecular genetic and genomic approaches to the study of medically important fungi.

Authors:  P T Magee; Cheryl Gale; Judith Berman; Dana Davis
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 2.  Strategies for the identification of virulence determinants in human pathogenic fungi.

Authors:  R Alonso-Monge; F Navarro-García; E Román; B Eisman; C Nombela; J Pla
Journal:  Curr Genet       Date:  2003-02-08       Impact factor: 3.886

3.  Phenotypic switching in Candida albicans is controlled by a SIR2 gene.

Authors:  J Pérez-Martín; J A Uría; A D Johnson
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

4.  Phosphorylation regulates polarisation of chitin synthesis in Candida albicans.

Authors:  Megan D Lenardon; Sarah A Milne; Héctor M Mora-Montes; Florian A R Kaffarnik; Scott C Peck; Alistair J P Brown; Carol A Munro; Neil A R Gow
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

5.  Insertion mutagenesis of the yeast Candida famata (Debaryomyces hansenii) by random integration of linear DNA fragments.

Authors:  Kostyantyn V Dmytruk; Andriy Y Voronovsky; Andriy A Sibirny
Journal:  Curr Genet       Date:  2006-06-13       Impact factor: 3.886

6.  Conserved fungal genes as potential targets for broad-spectrum antifungal drug discovery.

Authors:  Mengping Liu; Matthew D Healy; Brian A Dougherty; Kim M Esposito; Trina C Maurice; Charles E Mazzucco; Robert E Bruccoleri; Daniel B Davison; Marybeth Frosco; John F Barrett; Ying-Kai Wang
Journal:  Eukaryot Cell       Date:  2006-04

7.  Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family.

Authors:  X Zhao; S-H Oh; K M Yeater; L L Hoyer
Journal:  Microbiology (Reading)       Date:  2005-05       Impact factor: 2.777

8.  The Candida albicans pescadillo homolog is required for normal hypha-to-yeast morphogenesis and yeast proliferation.

Authors:  Junqing Shen; Leah E Cowen; April M Griffin; Leon Chan; Julia R Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

9.  Disruption of the Candida albicans CYB5 gene results in increased azole sensitivity.

Authors:  K M Rogers; C A Pierson; N T Culbertson; C Mo; A M Sturm; J Eckstein; R Barbuch; N D Lees; M Bard
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Rare homologous gene targeting in Histoplasma capsulatum: disruption of the URA5Hc gene by allelic replacement.

Authors:  J P Woods; D M Retallack; E L Heinecke; W E Goldman
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.